| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |